Genomic & Biopharma NewsOsmium-based compound seen to target cancer cells from inside
Researchers have witnessed - for the first time - cancer cells being targeted and destroyed from the inside, by an organo-metal compound discovered by the University of Warwick.
|News Medical Life Sciences, 2017-02-13 12:19:41|
New brain cancer coalition announces precision medicine study
Philadelphia Coalition for a Cure (PC4C), a newly launched cooperative clinical diagnostics and research initiative announced that it will collaborate in a study together with Children’s Hospital of Orange County (CHOC) directed to the study and diagnosis of adult and pediatric brain tumors. To support the study, CHOC and PC4C members selected NantHealth, Inc., (NASDAQ: NH), a ...
|Transcriptome Research & Industry News, 2017-02-13 12:09:32|
Reprogramming liver cells to become pancreatic cells may help diabetic patients
It is now possible to reprogram cells from the liver into the precursor cells that give rise to the pancreas by altering the activity of a single gene.
|News Medical Life Sciences, 2017-02-13 12:08:34|
UK’s Acacia to file rescue PONV drug in the US
UK firm Acacia Pharma says a fourth and pivotal late-stage study assessing Baremsis as a rescue treatment for patients experiencing post-operative nausea & vomiting (PONV) despite prophylactic therapy has hit its targets, pushing the drug closer to US filing.
|PharmaTimes, 2017-02-13 12:00:09|
Duke Health researchers identify potential new drug target for Huntington's disease
The loss of motor function and mental acuity associated with Huntington's disease might be treatable by restoring a cellular quality control process, which Duke Health researchers have identified as a key factor in the degenerative illness.
|News Medical Life Sciences, 2017-02-13 11:46:43|
Testing for circulating tumour cells could help predict bladder cancer patients’ prognosis
New research indicates that about one-quarter of patients with bladder cancer treated with radical surgery on curative intent have detectable levels of tumour cells circulating in their blood.
|News Medical Life Sciences, 2017-02-13 11:40:19|
LMU study shows crucial role of microRNAs in protecting precursors of neurons
Programmed cell death is an integral part of embryonic development. Exploring the regulation of the process, Ludwig-Maximilians-Universitaet in Munich researchers have shown that so-called microRNAs protect the precursors of neurons from 'precocious' elimination.
|News Medical Life Sciences, 2017-02-13 11:23:05|
Study elucidates mechanism behind building army of killer cells to fight infection
A few days after a viral infection, countless killer cells swarm out to track down and kill infected body cells.
|News Medical Life Sciences, 2017-02-13 11:15:29|
Sanofi to sell OTC products to Ipsen
Sanofi is selling certain European rights to five consumer healthcare products to fellow French drugmaker Ipsen, in a move that will help progress its planned asset swap deal with Boehringer Ingelheim.
|PharmaTimes, 2017-02-13 11:08:13|